Catabasis Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
CATB
CUSIP
14875P206
All holders as of
Q2 2021
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2021 Q2 63 48.5 M $102 M
2021 Q1 71 13.6 M $39.2 M
2020 Q4 74 7.07 M $15.1 M
2020 Q3 58 8.25 M $51.1 M
2020 Q2 54 8.01 M $51.5 M
2020 Q1 31 6.02 M $24.9 M
2019 Q4 31 5.37 M $31.8 M
2019 Q3 28 4.42 M $23.9 M
2019 Q2 26 4.36 M $35.1 M
2019 Q1 30 4.18 M $33.1 M
2018 Q4 25 2.14 M $9.35 M